» Authors » A C Boyter

A C Boyter

Explore the profile of A C Boyter including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 83
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Covvey J, Al-Balushi A, Boyter A, Gourlay Y
J Hosp Infect . 2015 Aug; 91(3):264-70. PMID: 26233780
Background: Medication-related incidents are an important consideration in enhancing patient safety in hospital care. The wide use of antimicrobial therapy in this population renders these medications particularly vulnerable to errors...
2.
Covvey J, Mullen A, Ryan M, Steinke D, Johnston B, Wood F, et al.
Int J Clin Pract . 2014 May; 68(10):1200-8. PMID: 24797899
Aim: To describe and compare adherence and persistence with maintenance therapies in patients with asthma or chronic obstructive pulmonary disease (COPD) in the United Kingdom (UK). Methods: A retrospective prescribing...
3.
Mabbott F, Mullen A, Smith A, Smith G, Boyter A
J Hosp Infect . 2011 Feb; 77(3):277-8. PMID: 21277652
No abstract available.
4.
Akram G, Thomson A, Boyter A, Morton M
Arch Dis Child . 2008 Mar; 93(8):695-700. PMID: 18337283
Objectives: To identify, characterise and evaluate UK websites providing information about attention deficit hyperactivity disorder (ADHD) and its pharmacological management. Design: Cross-sectional survey of websites identified by entering "ADHD" into...
5.
Allanson A, Cotton M, Tettey J, Boyter A
J Pharm Biomed Anal . 2007 May; 44(4):963-9. PMID: 17531423
A high performance liquid chromatography method has been developed that allows quantification of concentrations of rifampicin in human plasma and blood spots. Rifampicin and papaverine hydrochloride (internal standard) were extracted...
6.
McLaughlin C, Bodasing N, Boyter A, Fenelon C, Fox J, Seaton R
QJM . 2005 Aug; 98(10):745-52. PMID: 16126741
Background: A high proportion of medical in-patients in the UK receive intravenous (IV) antibiotic therapy. This may be inappropriate in non-severe infections, or unnecessarily prolonged. Aim: To assess the impact...
7.
Watson D, Oliveira E, Boyter A, Dagg K
J Pharm Pharmacol . 2001 Apr; 53(3):413-6. PMID: 11291759
Monitoring of drugs (such as theophylline) with a narrow therapeutic window could be simplified if patients were able to submit blood spots for analysis. This could reduce clinic attendance for...
8.
Seaton R, Nathwani D, Williams F, Boyter A
J Infect . 1999 Dec; 39(2):129-33. PMID: 10609530
Outpatient and home parenteral antibiotic therapy (OHPAT) is under-utilized in the U.K. We performed a feasibility study over a 5-month period in a regional U.K. infection unit. After exclusions, 183...
9.
Seaton R, Boyter A, Williams F, Laing R, Nathwani D
J Antimicrob Chemother . 1998 Feb; 40(6):912-3. PMID: 9462451
No abstract available.
10.
Boyter A, Stephen J, Fegan P, Nathwani D
J Antimicrob Chemother . 1997 Feb; 39(2):286-8. PMID: 9069557
No abstract available.